Search results

Blog

Moving Your Drug Forward to Preclinical Trials

Sep 30, 2021
- Preclinical Research
- Regulatory Affairs
ISSUE NO. 18 — Planning Your First-in-Human Trial

Aug 27, 2021
- Clinical Trials
ISSUE NO. 6 — Hybrid Medicines and 505(b)(2) NDA Approval Pathways

Dec 1, 2018
- Regulatory Affairs
- End-to-End Program
ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

Nov 1, 2024
ISSUE NO. 31 — The Advantages of Conducting Early-Phase Clinical Research in Canada

Feb 13, 2023
- Regulatory Affairs
Blog

Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig

Jul 10, 2025

Explore advancements in cell and gene therapy studies, like NHP research models and germline integration, as Kaylyn Koenig, Principal Scientist at Altasciences, shares highlights from attending ASGCT 2025.
- Preclinical Research
Scientific Publication

CNS Drug Development Solutions, Simplified.

Jun 23, 2025
- End-to-End Program